LZTS1 downregulation confers paclitaxel resistance and is associated with worse prognosis in breast cancer

Francesca Lovat, Hideshi Ishii, Monica Schiappacassi, Matteo Fassan, Mattia Barbareschi, Enzo Galligioni, Pierluigi Gasparini, Gustavo Baldassarre, Carlo M. Croce, Andrea Vecchione

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'LZTS1 downregulation confers paclitaxel resistance and is associated with worse prognosis in breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences